Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6676 AL 6690

Detection of Alzheimer's Disease Neuropathology in Chronic Kidney Disease: Current State and Future Directions

Gupta A, Mielke MM, Tariot PN.

J Am Geriatr Soc. 2025 Oct;73(10):2995-3001. doi: 10.1111/jgs.19554. Epub 2025 Jun 17.

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.

Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.

Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational Research

Titze-de-Almeida SS, Marina CL, Ramos MV, Silva LDDS, Brandão PRP, Bispo DDC, Von Glehn F, Titze-de-Almeida R.

Int J Mol Sci. 2025 Aug 25;26(17):8246. doi: 10.3390/ijms26178246.

Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers

Arslan B, Zetterberg H, Ashton NJ.

J Alzheimers Dis. 2025 Nov;108(1):75-78. doi: 10.1177/13872877251375101. Epub 2025 Sep 9.

Next-generation biosensor technologies for Alzheimer's disease: Innovations in diagnosis, monitoring, and treatment

Yin C, Tang X, Zeng J, Wang Z, Mi J, Liang Y, Qin D, Feng Q, Wu A.

Ageing Res Rev. 2026 Jan;114:102954. doi: 10.1016/j.arr.2025.102954. Epub 2025 Nov 19.

Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease

Goswami S, Hartz SM, Oliver A, Jackson S, Ogungbenle T, Evans A, Linnenbringer E, Moulder KL, Morris JC, Mozersky J.

JAMA Netw Open. 2025 May 1;8(5):e252919. doi: 10.1001/jamanetworkopen.2025.2919.

SCD-plus features and AD biomarkers in cognitively unimpaired samples: A meta-analytic approach for nine cohort studies

Kuhn E, Klinger HM, Amariglio RE, Wagner M, Jessen F, Düzel E, Heneka MT, Chételat G, Rentz DM, Sperling RA, Ebenau JL, Butterbrod E, Van Der Flier WM, Sikkes SAM, Teunnissen CE, Van Harten AC, Van De Giessen EM, Rami L, Tort A, Sánchez Benavides G, Gifford KA, Van Hulle C, Buckley RF; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle flagship study of ageing, A4 Study Team; DELCODE Study; Harvard Aging Brain Study.

Alzheimers Dement. 2025 May;21(5):e14307. doi: 10.1002/alz.14307. Epub 2025 Feb 22.

Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer's Disease: A Cross-sectional Study

Luca A, Politis A, Luca M, Ferri R, Grasso M, Drago F, Nicoletti A, Serretti A.

Curr Alzheimer Res. 2025;22(5):396-402. doi: 10.2174/0115672050384313250612045355.

Diagnosis of Alzheimer's disease: Recommendations from the French Federation of Memory Clinics

Dumurgier J, Défontaines B, Gallouj K, Garcin B, Garnier-Crussard A, Lagarde J, Pauly JM, Rollin Sillaire A, Rouch-Leroyer I, Sarazin M, Verny M, Wallon D.

Rev Neurol (Paris). 2025 Dec;181(10):1021-1029. doi: 10.1016/j.neurol.2025.09.004. Epub 2025 Sep 30.

A Comprehensive Review on Deep Learning Techniques in Alzheimer's Disease Diagnosis

Mahavar A, Patel A, Patel A.

Curr Top Med Chem. 2025;25(4):335-349. doi: 10.2174/0115680266310776240524061252.

Quantum dots in neurotheranostics for the treatment of Alzheimer's disease

Sharma T, Bashir B, Sharma P, Andotra N, Singh SK, Singh TG, Vishwas S.

Ageing Res Rev. 2025 Dec;112:102876. doi: 10.1016/j.arr.2025.102876. Epub 2025 Aug 20.

Paving the way for Alzheimer's disease blood-based biomarkers in primary care

Erickson CM, Largent EA, O'Brien KS.

Alzheimers Dement. 2025 Jan;21(1):e14203. doi: 10.1002/alz.14203. Epub 2024 Dec 30.

P-tau217 as a Biomarker in Alzheimer's Disease: Applications in Latin American Populations

Varela-Vidales CA, Martínez-Hernández A, Hernández-Castellanos E, Delgado-Lara DLC.

Int J Mol Sci. 2025 Jul 10;26(14):6633. doi: 10.3390/ijms26146633.

The Alzheimer's Disease Continuum - A New Diagnostic Approach

Drake J, Warren S, Wu CK.

R I Med J (2013). 2025 May 1;108(5):8-12.

Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice

Hazan J, Liu KY, Isaacs JD, Howard R.

Alzheimers Dement. 2025 Mar;21(3):e70113. doi: 10.1002/alz.70113.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias